Using the chemotherapeutic drug gemcitabine (GEM), which selectively depletes MDSC in tumor-bearing animals (36), we confirm that highly proliferating Ly6ChiMHCII- myeloid cells are critical for the onset of EAE, and show that their induction is not required for OM-MOG immune tolerance. The gene discussed is MOG; the disease is ocular melanoma.